NVAX Sep 2024 3.000 call
| Previous Close | 1.6300 |
| Open | 1.5200 |
| Bid | 0.6100 |
| Ask | 2.3900 |
| Strike | 3.00 |
| Expire Date | 2024-09-20 |
| Day's Range | 1.5200 - 1.6300 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 60 |
Barrons.comNovavax Stock Surges 120% on $1.4 Billion Deal With Sanofi
Novavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine could put it out of business, said it reached a $1.4 billion deal with French company Sanofi to commercialize its existing treatment and develop a new one. Shares spiked 120% in premarket trading to $10.02. Sanofi agreed to pay $500 million upfront and spend another $700 million when the company hits development, regulatory and launch milestones, Novavax said in a statement Friday.
Barrons.comThese Stocks Are Moving the Most Today: Novavax, Akamai, Tesla, Taiwan Semi, SoundHound, JFrog, Dropbox, Yelp, and More
Novavax stock surges after vaccine maker signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai Technologies misses estimates, and Elon Musk says Tesla to spend more than $500 million to expand its Supercharger network.
Yahoo Finance UKTrending tickers: TSMC, Novavax, Anglo American and IAG
The latest investor updates on stocks that are trending on Friday
